The Cranial Nerve Program, under the direction of Georgios Zenonos, MD, along with Paul Gardner, MD, joins experts in a variety of medical disciplines, including neurosurgery, neurology, neurophysiology, radiology, anesthesia, neuro-oncology, and neuro-otology with the intent of providing the most advanced care for a variety of brain disorders. The goal of the program is to provide the very best outcomes for patients with a variety of disorders in the most minimally invasive manner.
Building upon the pioneering work accomplished at the University of Pittsburgh by former long-time chairman Peter J. Jannetta, MD, with his ground-breaking development of microvascular decompression (MVD), our Cranial Nerve Program is an international leader in the management of trigeminal neuralgia, hemifacial spasm and glossopharyngeal neuralgia, among over cranial nerve disorders.
The center is driven by outcome-based clinical research and basic science research projects aimed at understanding the biologic mechanisms of diseases within the realm of the center. In recent years, this research has resulted in improved outcomes for patients and new therapies for a variety of disorders.